Methylphenidate Extended-release Tablet, Orally Disintegrating
Product Images NDC 62542-350

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Methylphenidate Extended-release (NDC 62542-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Methylphenidate Extended Release Tablets 1)

Figure 1 (Methylphenidate Extended Release Tablets 1)
This is a chemical compound named CyaH1aNOy with a molecular weight of 233.31.*
FDA Label Image

Figure 2 (Methylphenidate Extended Release Tablets 2)

FDA Label Image

Figure 3 (Methylphenidate Extended Release Tablets 3)

FDA Label Image

8.6 mg Tablet (Methylphenidate Extended Release Tablets 4)

8.6 mg Tablet (Methylphenidate Extended Release Tablets 4)
This is a prescription for Methylphenidate Extended-Release 8.6 mg orally disintegrating tablets. The usual dosage instructions should be referred to on the package insert. It is important not to crush or chew the tablets. Each tablet contains 8.6 mg of methylphenidate hydrochloride. The medication should be stored at controlled room temperature. The product comes with 30 tablets and should be accompanied by a Medication Guide for each patient. The manufacturer is Noca Therapeutics LP, located in Denver, CO 80237.*
FDA Label Image

17.3 mg (Methylphenidate Extended Release Tablets 5)

17.3 mg (Methylphenidate Extended Release Tablets 5)
This is a prescription medication with the NDC 62542-250-31, intended for oral use only. It is an extended-release form of Methylphenidate. Each tablet contains 17.3 mg of Methylphenidate, equivalent to that in a 20 mg strength tablet. The package contains 30 orally disintegrating tablets and should not be crushed or chewed. Please refer to the package insert for full prescribing information and dosage instructions.*
FDA Label Image

25.9 mg (Methylphenidate Extended Release Tablets 6)

25.9 mg (Methylphenidate Extended Release Tablets 6)
This text provides dosage and usage information for Methylphenidate Extended-Release Orally Disintegrating Tablets. It contains details about the controlled room temperature storage requirements and warnings not to crush or chew tablets. The product comes in a package of 30 tablets. Dosage recommendations should be followed as per package insert for full prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.